Trastuzumab emtansine in the treatment of HER2-positive metastatic breast cancer in Japanese patients
Masataka SawakiDepartment of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, JapanAbstract: Anti-HER2 agents, such as trastuzumab, lapatinib, trastuzumab emtansine (T-DM1), and pertuzumab, are standard agents in the treatment of breast cancer overexpressing the human epidermal growth factor...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-04-01
|
| Series: | Breast Cancer : Targets and Therapy |
| Online Access: | http://www.dovepress.com/trastuzumab-emtansine-in-the-treatment-of-her2-positive-metastatic-bre-a16469 |